Larvol Delta - Biomea-Fusion-to-Host-Conference-Call-to-Announce-Topline-Results-from-Phase-II-COVALENT111-Study-in-Patients-with-Type-2-Diabetes-T2D

icovamenib (BMF-219) - Biomea Fusion

https://www.globenewswire.com/news-release/2024/12/16/2997949/0/en/Biomea-Fusion-to-Host-Conference-Call-to-Announce-Topline-Results-from-Phase-II-COVALENT-111-Study-in-Patients-with-Type-2-Diabetes-T2D.html

Dec 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next